Selection of patients with hepatocellular carcinoma before liver transplantation:need to combine alpha-fetoprotein with morphology?

被引:2
|
作者
Christian Toso [1 ]
Gilles Mentha [1 ]
Pietro Majno [1 ]
机构
[1] Abdominal and Transplant Surgery,University Hospitals of Geneva
关键词
HCC; AFP; Selection of patients with hepatocellular carcinoma before liver transplantation;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
Liver transplantation is the best treatment for selected patients with unresectable hepatocellular carcinoma (HCC). While candidate selection has been historically based on the restrictive Milan
引用
收藏
页码:460 / 461
页数:2
相关论文
共 50 条
  • [1] Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology?
    Toso, Christian
    Mentha, Gilles
    Majno, Pietro
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (05) : 460 - 461
  • [2] Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
    Charriere, Berenice
    Maulat, Charlotte
    Suc, Bertrand
    Muscari, Fabrice
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (21) : 881 - 890
  • [3] Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
    Bérénice Charrière
    Charlotte Maulat
    Bertrand Suc
    Fabrice Muscari
    World Journal of Hepatology, 2016, (21) : 881 - 890
  • [4] Liver transplantation for hepatocellular carcinoma: alpha-fetoprotein should be included in selection criteria
    Pommergaard, Hans-Christian
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
  • [5] Alpha-fetoprotein in liver transplantation for hepatocellular carcinoma: The lower, the better
    Mazzaferro, Vincenzo
    Busset, Michele Droz Dit
    Bhoori, Sherrie
    HEPATOLOGY, 2018, 68 (02) : 775 - 777
  • [6] Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it?
    Lai, Quirino
    Avolio, Alfonso W.
    Manzia, Tommaso M.
    Agnes, Salvatore
    Tisone, Giuseppe
    Berloco, Pasquale B.
    Rossi, Massimo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2011, 26 (03): : 153 - 159
  • [7] Role of Alpha-Fetoprotein as Predictor of Recurrence in Patients with Hepatocellular Carcinoma Treated with Bridge Therapies before Liver Transplantation
    Lai, Quirino
    Mennini, Gianluca
    Nudo, Francesco
    Spoletini, Gabriele
    Corradini, Stefano Ginanni
    Berloco, Pasquale B.
    Rossi, Massimo
    LIVER TRANSPLANTATION, 2011, 17 (06) : S218 - S218
  • [8] Impact of the alpha-Fetoprotein model for patient selection for Liver Transplantation for Hepatocellular Carcinoma, a French experience
    Brusset, B.
    Louis, Q. J.
    Dumortier, J.
    Cherqui, D.
    Pageaux, G. -P.
    Dharancy, S.
    Radenne, S.
    Samuel, D.
    Thomas, D.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S204 - S205
  • [9] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA WITHIN MILAN CRITERIA IN PATIENTS WITH ELEVATED ALPHA-FETOPROTEIN
    Sanchez Rodriguez, Eugenia
    Rios Leon, Raquel
    Graus Morales, Javier
    Gea Rodriguez, Francisco
    Garcia Gonzalez, Miguel
    Albillos, Agustin
    TRANSPLANT INTERNATIONAL, 2019, 32 : 346 - 346
  • [10] Alpha-Fetoprotein Gradient before Liver Transplantation as a Predictor of Post Transplant Tumor Recurrence in Patients with Hepatocellular Carcinoma.
    Kashkoush, S. M.
    El Moghazy, W.
    Kawahara, T.
    Gala-Lopez, B.
    Kneteman, N. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 469 - 469